Related Experiment Video
Updated: Jun 18, 2026
10:37
A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells
Published on: August 22, 2025
Diagnosing breast cancer using Raman spectroscopy: prospective analysis
Abigail S Haka1, Zoya Volynskaya, Joseph A Gardecki
1Massachusetts Institute of Technology, George R. Harrison Spectroscopy Laboratory, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA. abh2005@med.cornell.edu
Journal of Biomedical Optics
|November 10, 2009
Summary
This study prospectively tested Raman spectroscopy for diagnosing breast tissues. The developed algorithm showed high accuracy in distinguishing cancerous from normal and benign tissues, demonstrating its clinical potential.
Area of Science:
- Biomedical Optics
- Medical Diagnostics
- Spectroscopy
Background:
- Raman spectroscopy offers a label-free method for biochemical analysis of tissues.
- Previous internal validation demonstrated an accurate algorithm for breast cancer diagnosis using Raman spectra.
- Prospective testing is crucial to assess real-world diagnostic performance and identify potential biases.
Purpose of the Study:
- To prospectively evaluate a Raman spectroscopy-based algorithm for diagnosing normal, benign, and malignant human breast tissues.
- To assess the diagnostic information and potential biases of spectroscopic measurements in a clinical setting.
- To validate the algorithm's performance on a large ex vivo clinical dataset mimicking the in vivo environment.
Main Methods:
- Collected Raman spectroscopic data from freshly excised surgical specimens.
- Examined 129 tissue sites from 21 patients.
- Applied a previously developed diagnostic algorithm to the prospective ex vivo data.
Main Results:
- Achieved 83% sensitivity and 93% specificity in distinguishing cancerous from normal and benign tissues.
- Reported a positive predictive value of 36% and a negative predictive value of 99%.
- Analyzed algorithm performance across different patient populations and examined sources of bias.
Conclusions:
- The prospective test demonstrates the clinical utility of Raman spectroscopy for breast tissue diagnosis.
- The algorithm shows promising accuracy, particularly a high negative predictive value, for identifying non-cancerous tissues.
- Further investigation into bias sources and performance in diverse populations is warranted for broader clinical adoption.
Related Concept Videos
01:20Raman Spectroscopy: Overview
The underlying principle of Raman spectroscopy is based on the interaction between light and matter, specifically molecules' inelastic scattering of photons. When a monochromatic beam of light, typically from a laser source, interacts with a sample, most scattered light has the same frequency as the incident light. This is known as Rayleigh scattering.
However, a small fraction of the scattered light exhibits a frequency shift due to the exchange of energy between the incident photons and the...
However, a small fraction of the scattered light exhibits a frequency shift due to the exchange of energy between the incident photons and the...
01:26Raman Spectroscopy Instrumentation: Overview
A conventional Raman spectrophotometer includes a laser source, a sample holding system, a wavelength selector, and a detector.
The monochromatic laser source, typically using visible or near-infrared radiation, generates a highly focused beam of light. This light interacts with the molecules of the sample, scattering some of the light. Liquid and gaseous samples are usually tested in ordinary glass capillaries, while solids can be analyzed as powders packed in capillaries or as potassium...
The monochromatic laser source, typically using visible or near-infrared radiation, generates a highly focused beam of light. This light interacts with the molecules of the sample, scattering some of the light. Liquid and gaseous samples are usually tested in ordinary glass capillaries, while solids can be analyzed as powders packed in capillaries or as potassium...